United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $13.54 billion. The enterprise value is $8.58 billion.
| Market Cap | 13.54B |
| Enterprise Value | 8.58B |
Important Dates
The last earnings date was Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 45.23 million shares outstanding. The number of shares has decreased by -1.52% in one year.
| Current Share Class | 45.23M |
| Shares Outstanding | 45.23M |
| Shares Change (YoY) | -1.52% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 1.76% |
| Owned by Institutions (%) | 95.05% |
| Float | 41.71M |
Valuation Ratios
The trailing PE ratio is 11.68 and the forward PE ratio is 10.72. UTHR's PEG ratio is 2.19.
| PE Ratio | 11.68 |
| Forward PE | 10.72 |
| PS Ratio | 4.36 |
| Forward PS | 4.03 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 1.92 |
| P/FCF Ratio | 12.64 |
| P/OCF Ratio | 9.88 |
| PEG Ratio | 2.19 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.37, with an EV/FCF ratio of 8.01.
| EV / Earnings | 6.90 |
| EV / Sales | 2.79 |
| EV / EBITDA | 5.37 |
| EV / EBIT | 5.65 |
| EV / FCF | 8.01 |
Financial Position
The company has a current ratio of 7.26
| Current Ratio | 7.26 |
| Quick Ratio | 6.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 48.32 |
Financial Efficiency
Return on equity (ROE) is 19.30% and return on invested capital (ROIC) is 14.19%.
| Return on Equity (ROE) | 19.30% |
| Return on Assets (ROA) | 12.96% |
| Return on Invested Capital (ROIC) | 14.19% |
| Return on Capital Employed (ROCE) | 20.56% |
| Revenue Per Employee | $2.36M |
| Profits Per Employee | $951,801 |
| Employee Count | 1,305 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, UTHR has paid $374.90 million in taxes.
| Income Tax | 374.90M |
| Effective Tax Rate | 23.18% |
Stock Price Statistics
The stock price has decreased by -7.00% in the last 52 weeks. The beta is 0.57, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -7.00% |
| 50-Day Moving Average | 297.98 |
| 200-Day Moving Average | 329.79 |
| Relative Strength Index (RSI) | 52.23 |
| Average Volume (20 Days) | 602,211 |
Short Selling Information
The latest short interest is 1.60 million, so 3.54% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short Previous Month | 1.57M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 3.13 |
Income Statement
In the last 12 months, UTHR had revenue of $3.08 billion and earned $1.24 billion in profits. Earnings per share was $25.63.
| Revenue | 3.08B |
| Gross Profit | 2.74B |
| Operating Income | 1.52B |
| Pretax Income | 1.40B |
| Net Income | 1.24B |
| EBITDA | 1.60B |
| EBIT | 1.52B |
| Earnings Per Share (EPS) | $25.63 |
Balance Sheet
The company has $3.05 billion in cash and n/a in debt, giving a net cash position of $4.97 billion or $109.81 per share.
| Cash & Cash Equivalents | 3.05B |
| Total Debt | n/a |
| Net Cash | 4.97B |
| Net Cash Per Share | $109.81 |
| Equity (Book Value) | 7.17B |
| Book Value Per Share | 158.65 |
| Working Capital | 3.30B |
Cash Flow
In the last 12 months, operating cash flow was $1.37 billion and capital expenditures -$300.30 million, giving a free cash flow of $1.07 billion.
| Operating Cash Flow | 1.37B |
| Capital Expenditures | -300.30M |
| Free Cash Flow | 1.07B |
| FCF Per Share | $23.68 |
Margins
Gross margin is 88.98%, with operating and profit margins of 49.30% and 40.36%.
| Gross Margin | 88.98% |
| Operating Margin | 49.30% |
| Pretax Margin | 52.54% |
| Profit Margin | 40.36% |
| EBITDA Margin | 51.89% |
| EBIT Margin | 49.30% |
| FCF Margin | 34.80% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.52% |
| Shareholder Yield | 1.52% |
| Earnings Yield | 9.17% |
| FCF Yield | 7.91% |
Analyst Forecast
The average price target for UTHR is $379.69, which is 26.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $379.69 |
| Price Target Difference | 26.81% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 7.56% |
| EPS Growth Forecast (5Y) | 10.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 15.22 and a Piotroski F-Score of 7.
| Altman Z-Score | 15.22 |
| Piotroski F-Score | 7 |